|
Current issue
Archive
Videos
Articles in press
About the journal
Supplements
Editorial board
Reviewers
Abstracting and indexing
Subscription
Contact
Instructions for authors
Publication charge
Ethical standards and procedures
Editorial System
Submit your Manuscript
|
3/2017
vol. 119 abstract:
Review paper
Ologen in surgical management of glaucomatous optic neuropathy
Irmina Duchnik
1, 2
,
Ewa Starzycka-Bigaj
2
,
Bożena Romanowska-Dixon
1, 2
Online publish date: 2018/06/05
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
The inability to inhibit the progression of optic nerve damage and visual field defects despite conservative therapy constitutes an indication for surgical intervention in glaucoma. Trabeculectomy is still the “golden standard” in glaucoma filtering surgery. The main causes of surgical failure are episcleral fibrosis and subconjunctival scarring, which especially affect younger people and patients after multiple operations on the same eye. In order to prolong the patency of the fistula and to achieve a lower intraocular pressure, anti-metabolic agents such as antimetabolites and collagen matrix ologen are used during glaucoma surgery. The aim of this study is to review the current literature on efficacy and safety of ologen use in glaucoma surgery.
keywords:
ologen collagen matrix, mitomycin C, intraocular pressure, trabeculectomy |
|
POLSKI
